Olivier Jacques Lantz

Title: Olivier Jacques Lantz: Innovator in Immunonutrition and Immune Modulation

Introduction

Olivier Jacques Lantz is a notable inventor based in Paris, France. He has made significant contributions to the fields of immunonutrition and immune modulation, holding 2 patents that address critical health issues related to cancer treatment and immune response.

Latest Patents

Lantz's latest patents include innovative methods and compositions aimed at improving patient outcomes during cancer therapy. One patent focuses on nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor. This invention provides methods and immunonutritional compositions that help preserve the innate and adaptive immune functions of the bone marrow, enhancing treatment efficacy and patient tolerance. Another patent involves the modulation of immune responses through the activity of Jα33 T cells and MR1 polypeptide. This invention outlines methods for regulating immune cell activity and offers a pharmaceutical composition that can aid in diagnosing intestinal diseases related to defects in these immune components.

Career Highlights

Throughout his career, Olivier Jacques Lantz has worked with prestigious institutions such as Institut Curie and the Institut National de la Santé et de la Recherche Médicale. His work has significantly advanced the understanding of immunonutrition and its applications in cancer therapy.

Collaborations

Lantz has collaborated with esteemed colleagues, including Emmanuel Treiner and Eduardo Schiffrin, contributing to the development of innovative solutions in the field of immunology.

Conclusion

Olivier Jacques Lantz is a pioneering inventor whose work in immunonutrition and immune modulation has the potential to transform cancer treatment and improve patient care. His contributions are invaluable in the ongoing quest for effective therapies in the medical field.